DIGITAL DOSE INHALER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Digital Dose Inhaler Market, By Product (Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Others), By Type (Branded and Generic), By Indication (Asthma, COPD, Others), By End User (Hospitals, Homecare Settings, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Apr 2024
Code : CMI6889
Pages :176
Formats :
Excel and PDF
Industry : Medical Devices

Market Concentration and Competitive Landscape

Digital Dose Inhaler Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Product Launch

Increasing adoption of organic growth strategies such as product launch by key market players is expected to drive the growth of digital dose inhaler market over the forecast period. For instance, in September 2020, Teva Pharmaceutical Industries Ltd., a pharmaceutical company, announced the launch of AirDuo Digihaler (fluticasone propionate and salmeterol) inhalation powder and ArmonAir Digihaler (fluticasone propionate) inhalation powder, two digital maintenance inhalers for patients with asthma. AirDuo Digihaler is a prescription medicine that is used to control symptoms of asthma and prevent symptoms such as wheezing in people 12 years of age and older. ArmonAir Digihaler is a prescription medicine for the long-term treatment of asthma in patients 12 years and older.

Key Players Insights